Two Sigma Advisers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $639K | Sell |
|
|||||
|
2025
Q1 | $1.38M | Sell |
|
|||||
|
2024
Q4 | $2.06M | Sell |
|
|||||
|
2024
Q3 | $8.4M | Sell |
|
|||||
|
2024
Q2 | $8.3M | Sell |
|
|||||
|
2024
Q1 | $10.4M | Buy |
|
|||||
|
2023
Q4 | $7.54M | Sell |
|
|||||
|
2023
Q3 | $6.91M | Sell |
|
|||||
|
2023
Q2 | $6.65M | Buy |
|
|||||
|
2023
Q1 | $4.25M | Buy |
|
|||||
|
2022
Q4 | $986K | Buy |
|
|||||
|
2022
Q3 | $211K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $544K | Buy |
|
|||||
|
2021
Q4 | $405K | Sell |
|
|||||
|
2021
Q3 | $584K | Sell |
|
|||||
|
2021
Q2 | $1.34M | Sell |
|
|||||
|
2021
Q1 | $2.03M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $960K | Sell |
|
|||||
|
2020
Q2 | $1.94M | Buy |
|
|||||
|
2020
Q1 | $1.31M | Buy |
|
|||||
|
2019
Q4 | $467K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $381K | Buy |
|
|||||
|
2019
Q1 | $410K | Buy |
|
|||||
|
2018
Q4 | $391K | Sell |
|
|||||
|
2018
Q3 | $457K | Buy |
|
|||||
|
2018
Q2 | $358K | Buy |
|